IDP-intwtLN10

General Information


DRACP ID  DRACP01781

Peptide Name   IDP-intwtLN10

Sequence  RRRRRRRAAKVVILKKATEYVHS

Sequence Length  23

UniProt ID  P04198  Q61976  P18444  P24793  P26014 

PubChem CID  Not available

Origin  Synthetics

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RG1, epithelial (glioblastoma, GMB), from surgical specimens from patients Glioblastoma Blastoma EC50>100 μM CYTELL assay 72-96 h Patent
12O53, epithelial (glioblastoma, GMB), from surgical specimens from patients Glioblastoma Blastoma EC50>100 μM CYTELL assay 72-96 h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01781

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C123H221N49O29

Absent amino acids  CDFGMNPQW

Common amino acids  R

Mass  324299

Pl  12.64

Basic residues  11

Acidic residues  1

Hydrophobic residues  8

Net charge  10

Boman Index  -11128

Hydrophobicity  -114.78

Aliphatic Index  84.78

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  67.73

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US2020/0157150A1

Patent Title  Anticancer Peptides

Other Iinformation  Patent Application; Family: 8s / 8ex; Family Jurisdictions: CA, CN, US, AU, JP, EP, WO, KR; Legal Status: Pending; Application No: 201816635902; Filed: Jul 31, 2018; Published: May 21, 2020; Earliest Priority: Aug 1, 2017

Other Published ID  AU2018311129A1  CA3071601A1  CN111436200A  EP3661947A1  JP2020529429A  KR20200032730A  WO2019025432A1 




DRACP is developed by Dr.Zheng's team.